(Q39154278)
Statements
1 reference
A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals (English)
1 reference
Yan Li
1 reference
Shaoping Sun
1 reference
Qi Chang
1 reference
Lei Zhang
1 reference
Gengnan Wang
1 reference
Weixing Chen
1 reference
Xiaoqing Miao
1 reference
Ying Zheng
1 reference
24 May 2013
1 reference
1 reference
10
1 reference
7
1 reference
2534-2542
1 reference
Identifiers
1 reference
1 reference